PURE · Pure Bioscience, Inc. · Documents
$0.09
+0.01 (+12.64%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our history of recurring operating losses, and negative cash flows from operating activities give rise to substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Jun 15, 2026
Market Cap
$11.70M
Shares
130.02M
Volume · Oct 23
22.5K
Avg daily vol (3M)
31.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2022-10-28 | 2022-07-31 | |
| 8-K | — | 2022-07-19 | 2022-07-15 | |
| 8-K | — | 2022-06-14 | — | |
| 10-Q | — | 2022-06-14 | 2022-04-30 | |
| 10-Q | — | 2022-03-15 | 2022-01-31 | |
| 8-K | — | 2022-03-15 | — | |
| 8-K | — | 2022-02-08 | 2022-02-03 | |
| DEF 14A | — | 2021-12-20 | — | |
| 10-Q | — | 2021-12-15 | 2021-10-31 | |
| 8-K | — | 2021-12-15 | — | |
| 8-K | — | 2021-10-28 | — | |
| 10-K | — | 2021-10-28 | 2021-07-31 | |
| 8-K | — | 2021-08-23 | 2021-08-19 | |
| 10-Q | — | 2021-06-15 | 2021-04-30 | |
| 8-K | — | 2021-06-15 | — | |
| 8-K | — | 2021-05-19 | 2021-05-17 | |
| 10-Q | — | 2021-03-15 | 2021-01-31 | |
| 8-K | — | 2021-03-15 | — | |
| 8-K | — | 2021-01-27 | 2021-01-20 | |
| 8-K | — | 2020-12-15 | — | |
| 10-Q | — | 2020-12-15 | 2020-10-31 | |
| DEF 14A | — | 2020-12-08 | — | |
| PRE 14A | — | 2020-11-20 | — | |
| 8-K | — | 2020-10-08 | — | |
| 10-K | — | 2020-10-08 | 2020-07-31 | |
| 8-K | — | 2020-06-11 | — | |
| 10-Q | — | 2020-06-11 | 2020-04-30 | |
| 8-K | — | 2020-05-21 | — | |
| 8-K | — | 2020-03-12 | — | |
| 10-Q | — | 2020-03-12 | 2020-01-31 | |
| 8-K | — | 2020-02-04 | 2020-01-29 |
Showing 51–81 of 81 filings